TARGACEPT, INC.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
- Website
- http://www.targacept.com
TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia
- First Posted Date
- 2009-10-28
- Last Posted Date
- 2013-09-13
- Lead Sponsor
- Targacept Inc.
- Target Recruit Count
- 184
- Registration Number
- NCT01003379
- Locations
- ๐ฎ๐ณ
Adhit Khan Neuropsychiatric Centre, Mangalore, Karnataka, India
๐ฎ๐ณDept. of Psychiatry, CSM University, Lucknow, Uttar Pradesh, India
๐ฎ๐ณDept. of Psychiatry, JSS University, Mysore, Karnataka, India
TC-5214 as Augmentation Therapy in Patients With Refractory Hypertension
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2013-09-13
- Lead Sponsor
- Targacept Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT00899977
- Locations
- ๐บ๐ธ
Piedmont Medical Research, Winston-Salem, North Carolina, United States
TC-5214 as add-on the Treatment of Major Depressive Disorder
Phase 2
Completed
- Conditions
- Major Depressive DisorderDepression
- Interventions
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- Targacept Inc.
- Target Recruit Count
- 574
- Registration Number
- NCT00692445
- Locations
- ๐ฎ๐ณ
Sri Kishna Prasad Psychiatric Nursing Home, Ahmedabad, Gujarat, India
๐ฎ๐ณGovernment Hospital for Mental Care, Dept. of Psychiatry, Visakhapatnam, Andhra Pradesh, India
๐ฎ๐ณHoly Family Hospital, Mumbai, Maharashtra, India
Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2008-01-15
- Lead Sponsor
- Targacept Inc.
- Target Recruit Count
- 450
- Registration Number
- NCT00593879
A Safety and Tolerability Single Ascending Dose Study in Healthy Volunteers
- First Posted Date
- 2007-12-31
- Last Posted Date
- 2008-07-18
- Lead Sponsor
- Targacept Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT00583544
- Locations
- ๐ซ๐ท
Forenap Pharma, Rouffache, France
A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)
Phase 2
Completed
- Conditions
- Age-Related Memory Disorders
- First Posted Date
- 2005-04-29
- Last Posted Date
- 2008-07-18
- Lead Sponsor
- Targacept Inc.
- Target Recruit Count
- 174
- Registration Number
- NCT00109564
- Locations
- ๐บ๐ธ
Pivotal Research Center, Peoria, Arizona, United States
๐บ๐ธMeridien Research, Tampa, Florida, United States
๐บ๐ธHartford Research, Florence, Kentucky, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath